EXOZYMES INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Mar 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $1.4M | — | $1.1M | — | — | — | $1.2M |
| SG&A Expense | — | $1.5M | — | $1.3M | — | — | — | $1.3M |
| Operating Income | — | $-3.0M | — | $-2.4M | — | — | — | $-2.5M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-2.9M | — | $-2.4M | — | — | — | $-2.3M |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-2.9M | — | $-2.4M | — | — | — | $-2.3M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $-0.33 | — | $-0.28 | — | — | — | $-0.27 |
| EPS (Diluted) | — | $-0.33 | — | $-0.28 | — | — | — | $-0.27 |
| Shares Outstanding (Basic) | 9.3M | 8.7M | 8.5M | 8.5M | 8.5M | 8.4M | 8.4M | 8.4M |
| Shares Outstanding (Diluted) | 9.3M | 8.7M | 8.5M | 8.5M | 8.5M | 8.4M | 8.4M | 8.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |